Table of Contents

company-logo

Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes simplex virus 1, which is in Phase I/II clinical trials for a range of solid tumors; and that is in Phase II clinical trials for patients with cutaneous squamous cell carcinoma. It is also developing RP2, which is in Phase I clinical trials for an anti-CTLA-4 antibody-like protein in order to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3 that is in Phase I clinical trials to express immune-activating proteins that stimulate T cells. Replimune Group, Inc. was founded in 2015 and is headquartered in Woburn, Massachusetts.

Replimune Dividend Announcement

• Replimune does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Replimune dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Replimune Dividend History

Replimune Dividend Yield

Replimune current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Replimune stock? Use our calculator to estimate your expected dividend yield:

Replimune Financial Ratios

P/E ratio-4.66
PEG ratio0.11
P/B ratio2.60
ROE-53.12%
Payout ratio0.00%
Current ratio10.11
Quick ratio10.11
Cash Ratio2.59

Replimune Dividend FAQ

Does Replimune stock pay dividends?
Replimune does not currently pay dividends to its shareholders.
Has Replimune ever paid a dividend?
No, Replimune has no a history of paying dividends to its shareholders. Replimune is not known for its dividend payments.
Why doesn't Replimune pay dividends?
There are several potential reasons why Replimune would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Replimune ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Replimune has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Replimune a dividend aristocrat?
Replimune is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Replimune a dividend king?
Replimune is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Replimune a dividend stock?
No, Replimune is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Replimune stocks?
To buy Replimune you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Replimune stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.